Clinical trials: Persistent Atrial Fibrillation
- Condition Persistent Atrial Fibrillation
- Funder type Industry (pharma, biotech, devices)
- Age group Children (under 18)
Atrial Fibrillation
European Carto® XP REgistry for Validating Specialized CFAE SOftware
The purpose of this prospective observational study (registry) is to determine the acute success rate of a complex fractionated atrial electrogram (CFAE) guided ablation procedure using a dedicated software and to determine the…
- Trial name
- EXPRESSO (NCT00812916)
- Testing
- RF ablation, using specialized CFAE software
- Where
- 13 sites in France, Germany and 1 more
- Volunteers
- 206 people
- Sponsor
- Biosense Webster EMEA